[Late onset hyperandrogenism caused by 3-beta-hydroxysteroid dehydrogenase deficiency]

Hyperandrogenism symptoms like hirsutism and acne are commonly observed in women with late onset conditions. While 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency is known to contribute to these symptoms, its frequency in post-pubertal hirsutism remains unclear. Prior research has shown that adrenal enzyme deficiencies can lead to elevated androgen levels, but no prior work had resolved how often this specific deficiency occurs in affected women. This gap motivated a retrospective study to better understand the prevalence of 3 beta-HSD deficiency in women with suspected hyperandrogenism. Earlier studies focused on diagnosing enzyme defects in adolescents, but this paper addresses the post-pubertal population. The lack of data on this specific group highlights the need for targeted diagnostic criteria. Researchers have not yet established a definitive prevalence rate for this deficiency in adult women. This uncertainty drove the need for a focused evaluation of 3 beta-HSD deficiency in a clinical setting.

The aim of this study was to evaluate the frequency of 3 beta-HSD deficiency in women presenting with hyperandrogenic symptoms after puberty. The specific problem addressed is the lack of data on how often this enzyme deficiency contributes to late onset hyperandrogenism. Researchers sought to determine whether this deficiency is a common cause of hirsutism and acne in adult women. The motivation for the study stems from the need to identify treatable causes of hyperandrogenism. By analyzing a cohort of patients with suspected 3 beta-HSD deficiency, the study aimed to clarify diagnostic patterns. The researchers focused on a specific diagnostic protocol involving adrenal stimulation tests. This approach allowed for a more precise assessment of enzyme activity. The study aimed to inform clinical guidelines for diagnosing and managing this condition.

The study employed a retrospective analysis of patients who consulted for hyperandrogenic symptoms between 1990 and 1992. Researchers selected 32 women with clinical signs of hyperandrogenism for evaluation. Each patient underwent adrenal stimulation with corticotrophin to assess enzyme function. Blood samples were collected to measure levels of 17-hydroxypregnenolone, 17-hydroxyprogesterone, dehydroepiandrosterone, and cortisol. The diagnostic criteria followed Pang’s established thresholds for 3 beta-HSD deficiency. Four specific hormonal ratios were used to classify deficiency as certain or probable. Patients were categorized based on how many criteria they met after stimulation. The study focused on post-pubertal women to better understand the late onset form of the deficiency.

Out of 32 patients evaluated, four were diagnosed with certain 3 beta-HSD deficiency and four with probable deficiency. The diagnostic criteria included elevated levels of 17-hydroxypregnenolone and dehydroepiandrosterone after stimulation. Patients meeting all four criteria were classified as having certain deficiency. Those meeting three criteria were considered probable cases. The study found that 8 out of 32 patients met the criteria for 3 beta-HSD deficiency. This suggests that the deficiency may be a relatively frequent cause of late onset hyperandrogenism. The mean age of patients was 27.5 years, with hirsutism being the most common symptom. The results indicate that this deficiency should be considered in young women with hyperandrogenic symptoms.

The authors propose that 3 beta-HSD deficiency is a relatively frequent cause of late onset hyperandrogenism in women. Their findings suggest that this deficiency should be carefully evaluated in patients presenting with hyperandrogenic symptoms. The study supports the use of adrenal stimulation tests to identify enzyme deficiencies. The researchers emphasize the importance of diagnosing this condition for appropriate treatment. They suggest that clinicians should consider this deficiency in young women with hirsutism or acne. The study highlights the need for targeted diagnostic criteria in post-pubertal populations. The authors propose that early detection can lead to effective therapeutic interventions. Their findings suggest that this deficiency may be more common than previously assumed.